Biotechnology - Pittsboro, North Carolina, United States
Apex is a boutique global strategy and business development consulting firm. They support life science-based clinical product development firms, primarily in oncology, infectious disease and transplant-related therapies. Jim Kappelman – Program Management, Technical Transfer and Supply Chain Service provider.Jim is a Program Management, Technical Transfer and Supply Chain Leader, providing services and solutions in technology transfer, manufacturing operations, and lifecycle management of biopharmaceuticals in all stages of the manufacturing process, including Drug Substance, Drug Product, and Finished Products. Jim is a forward-thinking leader across upstream and downstream biopharmaceutical production, making people, processes, and systems more efficient and effective, optimizing resources, delivering cost savings, and improving business performance, resulting in bottom line profits and organizational excellence. Jim offers a strong leadership presence with sound judgment, defining strategic vision, generating operational success, and delivering results across the organization. Jim has worked on late‐stage development and launch of well‐known biopharmaceuticals such as Prevnar‐13, Enbrel, Humira, Retacrit. Late-stage work on DEN‐204 (Takeda's late‐stage Dengue vaccine), F-627 (Evive's Biosimilar to Neulasta). Successful IND file for Kaidias' NK Cell Therapy. For more information contact Jim at: P.224.632.0500 or email Jim at: james.kappelman@gmail.com